retatrutide type 2 diabetes trial results 2024 2025 ๐จ Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. ๐ Mean body weight change at 80 weeks: โฌ๏ธ RetatrutideโA Game Changer in Obesity
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 28 - Sep 2


























